Lilly ICOS LLC (“Lily”), a young biotech start-up, is going to launch a new drug Cialis for male impotence treatment. In the existing ED drug market, Viagra has gained a huge success and Pfizer is accelerating its marketing pace. The problem with Lily is which patient segment to target and how to position itself in the marketplace in launching the Cialis. II. Alternatives:
1) Follow a Beat Strategy and Come Up with a Differentiated Positioning + High profit prospect by reaching a broad market including current users, dropouts and new users + Easy to build the brand by differentiation of 36-hour effectiveness, more flexibilities and rare visual irregularities + Consistent with Lily’s innovative marketing strategy of integrating into product development and introduction (i.e. “first-” and “best-in-class”) - High risk as a new entrant due to Viagra’s domination in the ED treatment marketplace - Significant marketing investment and innovative marketing tactics are required to make the differentiation - Lack of competency to convince the physicians of its superiority and difficult to persuade the current Viagra users to switch to Cialis 2) Follow a Compete Strategy and Go Head-to-Head with Viagra’s Positioning + Seize the competitor’s users and re-capture the dropouts as 90% of Viagra currents users and 84% dropouts are interested in trying the new drug + Quicken its prevalence by making analogous positioning, i.e. similar level of price and target customer, etc. + Save marketing costs on segmentation and targeting
- Fierce competition to confront directly with the ED treatment giant Viagra which has five-year history - Me-too positioning is not consistent with Lily’s focus on development of innovative drugs and competitor may fight back - The characteristics such as flexibility and less onset time may be ignored by customers 3) Follow a Niche Strategy and Target a Specific Segment
+ Modest competition and lower...